50474-802 : Neupro 2 mg/24h Transdermal Patch, Extended Release
| NDC: | 50474-802 |
| Labeler: | Ucb, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Neupro |
| Dosage Form: | Transdermal Patch, Extended Release |
| Application #: | NDA021829 |
| Rev. Date: |
NDC Package Codes:
- 50474-802-03: 30 POUCH IN 1 CARTON (50474‑802‑03) > 1 PATCH IN 1 POUCH > 24 H IN 1 PATCH
- 50474-802-17: 7 POUCH IN 1 CARTON (50474‑802‑17) > 1 PATCH IN 1 POUCH > 24 H IN 1 PATCH
Active Ingredients:
- Rotigotine
Dosage Strength:
- 2 mg/24h
Pharmaceutical Classes:
- Dopamine Agonists [MoA]
- Nonergot Dopamine Agonist [EPC]
Related Products:
Based on records with the same trade name.- 50474-801 Neupro 1 mg/24h Transdermal Patch, Extended Release by Ucb, Inc.
- 50474-803 Neupro 3 mg/24h Transdermal Patch, Extended Release by Ucb, Inc.
- 50474-804 Neupro 4 mg/24h Transdermal Patch, Extended Release by Ucb, Inc.
- 50474-805 Neupro 6 mg/24h Transdermal Patch, Extended Release by Ucb, Inc.
- 50474-806 Neupro 8 mg/24h Transdermal Patch, Extended Release by Ucb, Inc.
- 50474-808 Neupro Kit by Ucb, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 50474-801Next: 50474-803 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.